APA (7th ed.) Citation

WY, W., TW, H., YH, S., CM, S., TH, W., CF, C., . . . PH, L. (2025). Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. International journal of medical sciences, 22(16), 4353. https://doi.org/10.7150/ijms.121880

Chicago Style (17th ed.) Citation

WY, Wang, et al. "Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma." International Journal of Medical Sciences 22, no. 16 (2025): 4353. https://doi.org/10.7150/ijms.121880.

MLA (9th ed.) Citation

WY, Wang, et al. "Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma." International Journal of Medical Sciences, vol. 22, no. 16, 2025, p. 4353, https://doi.org/10.7150/ijms.121880.